267 related articles for article (PubMed ID: 19668335)
1. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome.
Rosenfeld JA; Ballif BC; Lucas A; Spence EJ; Powell C; Aylsworth AS; Torchia BA; Shaffer LG
PLoS One; 2009 Aug; 4(8):e6568. PubMed ID: 19668335
[TBL] [Abstract][Full Text] [Related]
2. Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype.
Balasubramanian M; Smith K; Basel-Vanagaite L; Feingold MF; Brock P; Gowans GC; Vasudevan PC; Cresswell L; Taylor EJ; Harris CJ; Friedman N; Moran R; Feret H; Zackai EH; Theisen A; Rosenfeld JA; Parker MJ
J Med Genet; 2011 May; 48(5):290-8. PubMed ID: 21343628
[TBL] [Abstract][Full Text] [Related]
3. Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1.
Gregoric Kumperscak H; Krgovic D; Vokac NK
J Int Med Res; 2016 Apr; 44(2):395-402. PubMed ID: 26811410
[TBL] [Abstract][Full Text] [Related]
4. SATB2-associated syndrome: Mechanisms, phenotype, and practical recommendations.
Zarate YA; Fish JL
Am J Med Genet A; 2017 Feb; 173(2):327-337. PubMed ID: 27774744
[TBL] [Abstract][Full Text] [Related]
5. Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing.
Zarate YA; Perry H; Ben-Omran T; Sellars EA; Stein Q; Almureikhi M; Simmons K; Klein O; Fish J; Feingold M; Douglas J; Kruer MC; Si Y; Mao R; McKnight D; Gibellini F; Retterer K; Slavotinek A
Am J Med Genet A; 2015 May; 167A(5):1026-32. PubMed ID: 25885067
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of SATB2 gene mutation in a child with Glass syndrome].
Lin M; Yao R; Lu J; Chen W; Xu Y; Li G; Yu T; Qing Y; Jin X; Wang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):712-715. PubMed ID: 31302918
[TBL] [Abstract][Full Text] [Related]
7. Intragenic duplication--a novel causative mechanism for SATB2-associated syndrome.
Liedén A; Kvarnung M; Nilssson D; Sahlin E; Lundberg ES
Am J Med Genet A; 2014 Dec; 164A(12):3083-7. PubMed ID: 25251319
[TBL] [Abstract][Full Text] [Related]
8. [Phenotypic and genetic analysis of a sibpair with partial deletion of SATB2 gene caused by 2q33.1 microdeletion].
Jin C; Lei Y; Liu J; Shan Q; Qian B; Zheng F; Chen P; Bai J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):628-631. PubMed ID: 31055823
[TBL] [Abstract][Full Text] [Related]
9. SATB2-associated syndrome in patients from Japan: Linguistic profiles.
Yamada M; Uehara T; Suzuki H; Takenouchi T; Yoshihashi H; Suzumura H; Mizuno S; Kosaki K
Am J Med Genet A; 2019 Jun; 179(6):896-899. PubMed ID: 30848049
[TBL] [Abstract][Full Text] [Related]
10. Deletion of 4.4 Mb at 2q33.2q33.3 May Cause Growth Deficiency in a Patient with Mental Retardation, Facial Dysmorphic Features and Speech Delay.
Papoulidis I; Paspaliaris V; Papageorgiou E; Siomou E; Dagklis T; Sotiriou S; Thomaidis L; Manolakos E
Cytogenet Genome Res; 2015; 145(1):19-24. PubMed ID: 25925190
[TBL] [Abstract][Full Text] [Related]
11. The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients.
Van Buggenhout G; Van Ravenswaaij-Arts C; Mc Maas N; Thoelen R; Vogels A; Smeets D; Salden I; Matthijs G; Fryns JP; Vermeesch JR
Eur J Med Genet; 2005; 48(3):276-89. PubMed ID: 16179223
[TBL] [Abstract][Full Text] [Related]
12. 4.5 Mb microdeletion in chromosome band 2q33.1 associated with learning disability and cleft palate.
Urquhart J; Black GC; Clayton-Smith J
Eur J Med Genet; 2009; 52(6):454-7. PubMed ID: 19576302
[TBL] [Abstract][Full Text] [Related]
13. Further delineation of the SATB2 phenotype.
Döcker D; Schubach M; Menzel M; Munz M; Spaich C; Biskup S; Bartholdi D
Eur J Hum Genet; 2014 Aug; 22(8):1034-9. PubMed ID: 24301056
[TBL] [Abstract][Full Text] [Related]
14. 2q33.1q34 Deletion in a Girl with Brain Anomalies and Anorectal Malformation.
Ronzoni L; Novelli A; Brisighelli G; Peron A; Triulzi F; Bianchi V; Leva E; Bedeschi MF
Cytogenet Genome Res; 2016; 150(1):23-28. PubMed ID: 27915340
[TBL] [Abstract][Full Text] [Related]
15. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
[TBL] [Abstract][Full Text] [Related]
16. Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2.
Zarate YA; Bosanko KA; Thomas MA; Miller DT; Cusmano-Ozog K; Martinez-Monseny A; Curry CJ; Graham JM; Velsher L; Bekheirnia MR; Seidel V; Dedousis D; Mitchell AL; DiMarino AM; Riess A; Balasubramanian M; Fish JL; Caffrey AR; Fleischer N; Pierson TM; Lacro RV
Clin Genet; 2021 Apr; 99(4):547-557. PubMed ID: 33381861
[TBL] [Abstract][Full Text] [Related]
17. SATB2-associated syndrome presenting with Rett-like phenotypes.
Lee JS; Yoo Y; Lim BC; Kim KJ; Choi M; Chae JH
Clin Genet; 2016 Jun; 89(6):728-32. PubMed ID: 26596517
[TBL] [Abstract][Full Text] [Related]
18. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome.
Shaffer LG; Theisen A; Bejjani BA; Ballif BC; Aylsworth AS; Lim C; McDonald M; Ellison JW; Kostiner D; Saitta S; Shaikh T
Genet Med; 2007 Sep; 9(9):607-16. PubMed ID: 17873649
[TBL] [Abstract][Full Text] [Related]
19. Toriello-Carey syndrome in a patient with a de novo balanced translocation [46,XY,t(2;14)(q33;q22)] interrupting SATB2.
Tegay DH; Chan KK; Leung L; Wang C; Burkett S; Stone G; Stanyon R; Toriello HV; Hatchwell E
Clin Genet; 2009 Mar; 75(3):259-64. PubMed ID: 19170718
[TBL] [Abstract][Full Text] [Related]
20. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
